Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Guilford's sNDA for Gliadel Wafer accepted by FDA

June 8, 2001

DDW presentation reports rapid vascular shutdown in tumor-bearing rats treated with AC-7700

June 8, 2001

AltaRex enters HCA collaboration with Epigen

June 7, 2001

Combination gene therapy with the cytokines IL-12 and IFN-alpha under study at Valentis

June 7, 2001

Protarga initiates multinational phase II program for Taxoprexin

June 7, 2001

New Celltech compounds useful for disease states associated with angiogenesis

June 7, 2001

Merck presents new series of indole-based tyrosine kinase inhibitors

June 7, 2001

GnRH antagonists useful for sex hormone-related disorders claimed by Neurocrine Biosciences

June 6, 2001

INGN-241: preclinical findings reported at American Society of Gene Therapy meeting

June 6, 2001

Intratumoral RPR/INGN-201 not associated with biosafety concerns in phase II trial

June 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...